100 related articles for article (PubMed ID: 19220446)
1. Cerebral white matter hyperintensities are not increased in patients with primary Sjögren's syndrome.
Harboe E; Beyer MK; Greve OJ; Gøransson LG; Tjensvoll AB; Kvaløy JT; Omdal R
Eur J Neurol; 2009 May; 16(5):576-81. PubMed ID: 19220446
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome.
Lin DF; Yan SM; Zhao Y; Zhang W; Li MT; Zeng XF; Zhang FC; Dong Y
Chin Med J (Engl); 2010 Nov; 123(22):3252-7. PubMed ID: 21163125
[TBL] [Abstract][Full Text] [Related]
3. A new kind of and reversible brainstem involvement in primary Sjögren's syndrome as an initial manifestation.
Yerdelen D; Karataş M; Alkan O; Tufan M
Int J Neurosci; 2010 Feb; 120(2):155-8. PubMed ID: 20199209
[TBL] [Abstract][Full Text] [Related]
4. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.
Coates T; Slavotinek JP; Rischmueller M; Schultz D; Anderson C; Dellamelva M; Sage MR; Gordon TP
J Rheumatol; 1999 Jun; 26(6):1301-5. PubMed ID: 10381047
[TBL] [Abstract][Full Text] [Related]
5. Loss of cerebral white matter in primary Sjögren's syndrome: a controlled volumetric magnetic resonance imaging study.
Lauvsnes MB; Beyer MK; Appenzeller S; Greve OJ; Harboe E; Gøransson LG; Tjensvoll AB; Omdal R
Eur J Neurol; 2014 Oct; 21(10):1324-9. PubMed ID: 24943133
[TBL] [Abstract][Full Text] [Related]
6. Disruption of brain white matter microstructure in primary Sjögren's syndrome: evidence from diffusion tensor imaging.
Segal BM; Mueller BA; Zhu X; Prosser R; Pogatchnik B; Holker E; Carpenter AF; Lim KO
Rheumatology (Oxford); 2010 Aug; 49(8):1530-9. PubMed ID: 20444862
[TBL] [Abstract][Full Text] [Related]
7. Signal hyperintensities on brain magnetic resonance imaging in patients with primary Sjögren syndrome and frequent episodic tension-type headache: relation to platelet serotonin level and disease activity.
Šarac H; Markeljević J; Erdeljić V; Josipović-Jelić Z; Hajnšek S; Klapan T; Batinica M; Baršić I; Sertic J; Dobrila Dintinjana R
J Rheumatol; 2013 Aug; 40(8):1360-6. PubMed ID: 23729799
[TBL] [Abstract][Full Text] [Related]
8. Primary Sjögren's syndrome activity and damage indices comparison.
Campar A; Isenberg DA
Eur J Clin Invest; 2010 Jul; 40(7):636-44. PubMed ID: 20482595
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome.
Matsumoto T; Morizane T; Aoki Y; Yamasaki S; Nakajima M; Enomoto N; Kobayashi S; Hashimoto H
Pathol Int; 2005 Feb; 55(2):70-6. PubMed ID: 15693852
[TBL] [Abstract][Full Text] [Related]
10. Intracranial hemodynamic changes in primary Sjögren syndrome: a transcranial Doppler case-control study.
Morreale M; Francia A; Marchione P; Manuppella F; Giacomini P
Neurol Sci; 2015 Sep; 36(9):1589-95. PubMed ID: 25868598
[TBL] [Abstract][Full Text] [Related]
11. Primary Sjogren's syndrome with central nervous system involvement.
Alhomoud IA; Bohlega SA; Alkawi MZ; Alsemari AM; Omer SM; Alsenani FM
Saudi Med J; 2009 Aug; 30(8):1067-72. PubMed ID: 19668890
[TBL] [Abstract][Full Text] [Related]
12. The impact of primary Sjögren's syndrome on female sexual function.
van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome.
Amin K; Lúdvíksdóttir D; Janson C; Nettelbladt O; Gudbjörnsson B; Valtysdóttir S; Björnsson E; Roomans GM; Boman G; Sevéus L; Venge P;
Respir Med; 2001 Nov; 95(11):904-10. PubMed ID: 11716205
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients.
Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G
Arthritis Rheum; 2007 Jul; 56(7):2223-31. PubMed ID: 17599741
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?
Niţescu D; Nicolau A; Caraiola S; Predeţeanu D; Ionescu R; Tănăsescu C
Rom J Intern Med; 2011; 49(4):295-300. PubMed ID: 22568275
[TBL] [Abstract][Full Text] [Related]
19. Increased percentage of CD8+CD28- T cells correlates with clinical activity in primary Sjögren's syndrome.
Smoleńska Z; Pawłowska J; Zdrojewski Z; Daca A; Bryl E
Cell Immunol; 2012; 278(1-2):143-51. PubMed ID: 22975109
[TBL] [Abstract][Full Text] [Related]
20. Neurological manifestations of primary Sjogren's syndrome.
Chai J; Logigian EL
Curr Opin Neurol; 2010 Oct; 23(5):509-13. PubMed ID: 20689426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
